
28- Physician-Scientist Series: Shaheen Lakhan, MD (Click Therapeutics)
07/13/22 • 48 min
What are the biggest barriers to digital therapeutics, and how will the field evolve down the line? How can we make MDs excited about entrepreneurship and innovation, like DTx for example, where their experience and clinical knowledge is actually needed?
In this episode, we answer all these questions and more, with our guest, Dr. Shaheen Lakhan.
Shaheen is the CMO of Click Therapeutics, A prescription digital therapeutics company that develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs.
Shaheen is a physician-scientist with over 15 years of experience in healthcare, academia, and industry focusing on neuroscience research and development.
Shaheen is board-certified in both neurology and pain medicine, with clinical training from Cleveland Clinic and Massachusetts General Hospital.
What are the biggest barriers to digital therapeutics, and how will the field evolve down the line? How can we make MDs excited about entrepreneurship and innovation, like DTx for example, where their experience and clinical knowledge is actually needed?
In this episode, we answer all these questions and more, with our guest, Dr. Shaheen Lakhan.
Shaheen is the CMO of Click Therapeutics, A prescription digital therapeutics company that develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs.
Shaheen is a physician-scientist with over 15 years of experience in healthcare, academia, and industry focusing on neuroscience research and development.
Shaheen is board-certified in both neurology and pain medicine, with clinical training from Cleveland Clinic and Massachusetts General Hospital.
Previous Episode

27- Physician-Executive Series: Olivia Cavlan, MD (Alchemab)
What kind of opportunities medical students have if they don’t want a traditional medical career? Why is it important to think about medical training as a platform, rather than a predetermined path? In this episode, we answer all of these questions and more, with our guest, Olivia Cavlan MD.
Olivia is Chief Corporate Development and Strategy Officer at Alchemab Therapeutics Ltd, a biotech company developing novel products for patients with hard-to-treat diseases by harnessing the power of naturally protective antibodies.
Olivia holds an MD in Medicine and a BSc in Pharmacology from Bristol University where she graduated with the top First Class Honors.
Next Episode

29- Physician-Artist Series: Mike Natter
How can medicine and art influence each other? What makes practicing medicine an art itself? In this special episode, we answer all these questions and more with our guest, Mike Natter, MD.
Mike is a freelance artist, contributor and writer at Philadelphia Inquirer. He was featured in “Art from the Frontlines: Visual Expressions from Medical Professionals During the COVID-19 Pandemic”, an exhibit that highlighted artwork created by healthcare professionals during the COVID-19 pandemic as well as in-depth interviews with the artists.
Mike has an MD from Thomas Jefferson University, a Medical Sciences Certificate from Columbia University in NYC, and a BA in Neuropsychology from Skidmore College.
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/physicians-off-the-beaten-path-260206/28-physician-scientist-series-shaheen-lakhan-md-click-therapeutics-30692919"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to 28- physician-scientist series: shaheen lakhan, md (click therapeutics) on goodpods" style="width: 225px" /> </a>
Copy